Physicians Realty Trust’s Stock Performance Forecasted to Remain Low Despite Market Woes in 2023.
March 29, 2023
Trending News ☀️
Despite the current market woes, experts are forecasting that the stock performance of Physicians Realty Trust ($NYSE:DOC) (PRT) will remain low in 2023. The stock closed at $13.94 in the last market session, which is a decrease of -3.40% from the previous day’s closing price of $14.43. Analysts have concluded that the market volatility due to the ongoing pandemic and political unrest has caused investors to be hesitant in investing in PRT stock. Furthermore, the company’s business operations have been affected by the pandemic, as its properties are mainly located in the healthcare industry, which has seen a significant decrease in demand due to the limitations imposed on medical services. Although its stock performance is expected to remain low in 2023, PRT’s future outlook is generally positive as the healthcare industry is expected to recover and demands for medical services are forecasted to increase over the next few years.
Additionally, PRT has taken proactive steps to reduce its debts, increase its liquidity and maximize its cash flow in order to ensure that it remains profitable during these challenging times. Therefore, although it is anticipated that Physicians Realty Trust’s stock performance will remain low in 2023, investors should remain optimistic about its future prospects as the company continues to take steps to ensure its long-term stability and success.
Share Price
This outlook is based on media sentiment, which has generally been negative so far. On Friday, PHYSICIANS REALTY TRUST opened at $13.8 and closed at $14.4, representing a 3.8% increase from the previous closing price of 13.8. This modest gain is unlikely to be indicative of a long-term trend, with analysts forecasting that the stock price will remain low in the near future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for DOC. More…
| Total Revenues | Net Income | Net Margin |
| 526.63 | 104.37 | – |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for DOC. More…
| Operations | Investing | Financing |
| 258.4 | -38.47 | -222.07 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for DOC. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 5.1k | 2.1k | 12.3 |
Key Ratios Snapshot
Some of the financial key ratios for DOC are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| – | – | 23.9% |
| FCF Margin | ROE | ROA |
| – | – | – |
Analysis
At GoodWhale, we have conducted an analysis of PHYSICIANS REALTY TRUST’s fundamentals and found that the company is a low risk investment in terms of financial and business aspects. We have also detected one risk warning in PHYSICIANS REALTY TRUST’s balance sheet. To gain access to this information, we recommend that investors become registered users of our platform so that they can benefit from all that GoodWhale has to offer. More…
Peers
The company competes with Healthcare Trust of America Inc, Global Medical REIT Inc, and Healthcare Realty Trust Inc.
– Healthcare Trust of America Inc ($NYSE:GMRE)
Global Medical REIT Inc is a publicly traded real estate investment trust focused on owning and leasing healthcare facilities. The company’s portfolio consists of medical office buildings, outpatient centers, senior housing, and other healthcare-related properties. As of 2022, the company’s market cap was 571.32M.
– Global Medical REIT Inc ($NYSE:HR)
Healthcare Realty Trust Incorporated is a real estate investment trust, which engages in the ownership, management, and development of healthcare properties. It operates through the following segments: Medical Office, On-Campus, In-fill, and Wellness. The company was founded by D. Edward Aldrich Jr. and John W. Heagy in January 1993 and is headquartered in Nashville, TN.
Summary
Physicians Realty Trust (PHYS) is a healthcare real estate investment trust that has seen its share price underperforming the market despite a recent uptick on the same day. The outlook for the stock in 2023 remains bearish, as the company has been receiving largely negative media sentiment. Investors should thus approach PHYS with caution and conduct further analysis to evaluate the stock’s potential return and risk.
This includes reviewing the company’s business performance, financials, dividend history and management. Furthermore, assessing the macroeconomic environment and industry trends of the healthcare sector will help provide insight into PHYS’s future performance.
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
